Interstitial Lung Disease Research Unit Biobank
Establish a interstitial lung disease (ILD) registry and biorepository to lead towards a further understanding of the disease.
| Condition(s) | Interstitial Lung Disease, Sarcoidosis, Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis, Hypersensitivity Pneumonitis |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | Establish a interstitial lung disease (ILD) registry and biorepository to lead towards a further understanding of the disease. |
| Who can participate | Inclusion Criteria: 1. The participant is a patient at TUKHS or has agreed to participate in a study approved by the KUMC Human Research Protection Program (HRPP) 2. The participant is being followed for the presence of autoimmune disease, ILD or other rare lung diseases at TUKHS. 3. The participant is ≥ 18 years of age. 4. The participant has signed an approved consent for this study (living patients only) |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | University of Kansas Medical Center |
| Locations | Kansas City, Kansas, United States |
| Start date | 2021-08-09 |
| NCT ID | NCT05392881 |
| Official listing | https://clinicaltrials.gov/study/NCT05392881 |